Recent studies have consolidated the pivotal role of Smads as intracellular
effecters of TGF-beta family members. Upon binding to their specific type
I and type II serine/threonine kinase receptors, each family member activat
es a particular subset of Smad proteins. Activated, receptor-regulated Smad
s form hetero-oligomeric complexes with common-partner Smads that transloca
te into the nucleus, where they control the expression of target genes in a
cell-type-specific manner. Smads appear to function not only as nuclear ef
fecters for TGF-beta family members, but as signal integrators within an ex
tensive intracellular network.